BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valderrama R, Pérez-Mateo M, Navarro S, Vázquez N, Sanjosé L, Adrián MJ, Estruch J. Multicenter double-blind trial of gabexate mesylate (FOY) in unselected patients with acute pancreatitis. Digestion. 1992;51:65-70. [PMID: 1499875 DOI: 10.1159/000200877] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Balakrishnan V, Philip M. Cytokines as predictors of severity in acute pancreatitis. J Gastroenterol Hepatol 1998;13:1177-9. [DOI: 10.1111/j.1440-1746.1998.tb00600.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
2 Taoka Y, Okajima K. Role of leukocytes in spinal cord injury in rats. J Neurotrauma 2000;17:219-29. [PMID: 10757327 DOI: 10.1089/neu.2000.17.219] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
3 Schmid S, Uhl W, Büchler MW. Protease-antiprotease interactions and the rationale for therapeutic protease inhibitors. Scand J Gastroenterol Suppl 1996;219:47-50. [PMID: 8865472 DOI: 10.3109/00365529609105000] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
4 Seta T, Noguchi Y, Shikata S, Nakayama T. Treatment of acute pancreatitis with protease inhibitors administered through intravenous infusion: an updated systematic review and meta-analysis. BMC Gastroenterol. 2014;14:102. [PMID: 24886242 DOI: 10.1186/1471-230x-14-102] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 3.6] [Reference Citation Analysis]
5 Heinrich S, Schäfer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006;243:154-168. [PMID: 16432347 DOI: 10.1097/01.sla.0000197334.58374.70] [Cited by in Crossref: 230] [Cited by in F6Publishing: 173] [Article Influence: 14.4] [Reference Citation Analysis]
6 Takeda K, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Hirota M, Kimura Y, Isaji S. JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13:42-47. [PMID: 16463210 DOI: 10.1007/s00534-005-1050-8] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 4.6] [Reference Citation Analysis]
7 Bi Y, Atwal T, Vege SS. Drug Therapy for Acute Pancreatitis. Curr Treat Options Gastro 2015;13:354-68. [DOI: 10.1007/s11938-015-0058-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
8 Mikami Y, Takeda K, Matsuda K, Qiu-Feng H, Fukuyama S, Egawa S, Sunamura M, Matsuno S. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas. 2005;30:248-253. [PMID: 15782103 DOI: 10.1097/01.mpa.0000153328.54569.28] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
9 Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, Lezzi G, Lichino E, Bruno F, Perri F. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther. 1998;12:237-245. [PMID: 9570258 DOI: 10.1046/j.1365-2036.1998.00295.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
10 Pezzilli R, Barakat B, Morselli-labate AM. Evaluation of the immunomodulatory effect of gabexate mesilate in patients with severe acute pancreatitis. Current Therapeutic Research 1998;59:710-6. [DOI: 10.1016/s0011-393x(98)85029-7] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
11 Afghani E, Pandol SJ, Shimosegawa T, Sutton R, Wu BU, Vege SS, Gorelick F, Hirota M, Windsor J, Lo SK, Freeman ML, Lerch MM, Tsuji Y, Melmed GY, Wassef W, Mayerle J. Acute Pancreatitis-Progress and Challenges: A Report on an International Symposium. Pancreas 2015;44:1195-210. [PMID: 26465949 DOI: 10.1097/MPA.0000000000000500] [Cited by in Crossref: 51] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
12 Yokoe M, Takada T, Mayumi T, Yoshida M, Isaji S, Wada K, Itoi T, Sata N, Gabata T, Igarashi H, Kataoka K, Hirota M, Kadoya M, Kitamura N, Kimura Y, Kiriyama S, Shirai K, Hattori T, Takeda K, Takeyama Y, Hirota M, Sekimoto M, Shikata S, Arata S, Hirata K. Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015. J Hepatobiliary Pancreat Sci. 2015;22:405-432. [PMID: 25973947 DOI: 10.1002/jhbp.259] [Cited by in Crossref: 192] [Cited by in F6Publishing: 150] [Article Influence: 27.4] [Reference Citation Analysis]
13 Takeda K, Yamauchi J, Shibuya K, Sunamura M, Mikami Y, Matsuno S. Benefit of continuous regional arterial infusion of protease inhibitor and antibiotic in the management of acute necrotizing pancreatitis. Pancreatology 2001;1:668-73. [PMID: 12120252 DOI: 10.1159/000055879] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
14 Pelagotti F, Cecchi M, Messori A. Use of gabexate mesylate in Italian hospitals: a multicentre observational study. J Clin Pharm Ther. 2003;28:191-196. [PMID: 12795778 DOI: 10.1046/j.1365-2710.2003.00480.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
15 Lee JH, An CS, Yun BS, Kang KS, Lee YA, Won SM, Gwag BJ, Cho SI, Hahm KB. Prevention effects of ND-07, a novel drug candidate with a potent antioxidative action and anti-inflammatory action, in animal models of severe acute pancreatitis. Eur J Pharmacol. 2012;687:28-38. [PMID: 22575522 DOI: 10.1016/j.ejphar.2012.04.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
16 Banfi R, Borselli G, Cappelletti S, Mari L, Aiazzi M, Taddei V. Gabexate mesilate and acute pancreatitis: an experience of evidence based drug information for improving rational drug use. Pharm World Sci 2005;27:121-3. [PMID: 15999923 DOI: 10.1007/s11096-004-5692-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
17 Piaścik M, Rydzewska G, Milewski J, Olszewski S, Furmanek M, Walecki J, Gabryelewicz A. The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study. Pancreas 2010;39:863-7. [PMID: 20431422 DOI: 10.1097/MPA.0b013e3181d37239] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 5.9] [Reference Citation Analysis]
18 De Campos T, Deree J, Coimbra R. From acute pancreatitis to end-organ injury: mechanisms of acute lung injury. Surg Infect (Larchmt). 2007;8:107-120. [PMID: 17381402 DOI: 10.1089/sur.2006.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
19 Berling R, Genell S, Ohlsson K. High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial. J Gastroenterol. 1994;29:479-485. [PMID: 7524945 DOI: 10.1007/bf02361247] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
20 Pederzoli P, Cavallini G, Falconi M, Bassi C. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.): A prospective, randomized, double-blind multicenter study. International Journal of Pancreatology 1993;14:117-24. [DOI: 10.1007/bf02786117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
21 Akbarshahi H, Rosendahl AH, Westergren-thorsson G, Andersson R. Acute lung injury in acute pancreatitis – Awaiting the big leap. Respiratory Medicine 2012;106:1199-210. [DOI: 10.1016/j.rmed.2012.06.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
22 Nagao S, Taguchi K, Sakai H, Yamasaki K, Watanabe H, Otagiri M, Maruyama T. Carbon monoxide-bound hemoglobin vesicles ameliorate multiorgan injuries induced by severe acute pancreatitis in mice by their anti-inflammatory and antioxidant properties. Int J Nanomedicine 2016;11:5611-20. [PMID: 27822039 DOI: 10.2147/IJN.S118185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
23 Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S, Fushimi K. Effect and cost of treatment for acute pancreatitis with or without gabexate mesylate: a propensity score analysis using a nationwide administrative database. Pancreas 2013;42:260-4. [PMID: 23000890 DOI: 10.1097/MPA.0b013e31826495a0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
24 Formela LJ, Galloway SW, Kingsnorth AN. Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6-13. [PMID: 7881958 DOI: 10.1002/bjs.1800820105] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 3.5] [Reference Citation Analysis]
25 Seta T, Noguchi Y, Shimada T, Shikata S, Fukui T. Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol. 2004;16:1287-1293. [PMID: 15618834 DOI: 10.1097/00042737-200412000-00009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
26 Hirata M, Hayashi I, Yoshimura K, Ishii K, Soma K, Ohwada T, Kakita A, Majima M. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats. Br J Pharmacol 2002;135:29-36. [PMID: 11786477 DOI: 10.1038/sj.bjp.0704462] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
27 Messori A, Rampazzo R, Scroccaro G, Olivato R, Bassi C, Falconi M, Pederzoli P, Martini N. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. Dig Dis Sci. 1995;40:734-738. [PMID: 7720462 DOI: 10.1007/bf02064970] [Cited by in Crossref: 55] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kambhampati S, Park W, Habtezion A. Pharmacologic therapy for acute pancreatitis. World J Gastroenterol 2014; 20(45): 16868-16880 [PMID: 25493000 DOI: 10.3748/wjg.v20.i45.16868] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
29 Rudin D, Kiss A, Wetz RV, Sottile VM. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol. 2007;22:977-983. [PMID: 17559376 DOI: 10.1111/j.1440-1746.2007.04928.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
30 Dar HA, Shah A, Javid G, Khan MA, Singh B, Sheikh NA, Ashraf A, Mohammad S. Randomized trial of high-dose rectal diclofenac suppository and epinephrine spray on duodenal papilla for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Indian J Gastroenterol 2021. [PMID: 34767149 DOI: 10.1007/s12664-021-01161-z] [Reference Citation Analysis]
31 Lee JK, Ryu JK, Park JK, Lee SH, Yoon WJ, Kim Y, Jung HC, Yoon YB. Effects of Nafamostat Mesilate on the Prevention of Cerulein-Induced Acute Pancreatitis. Pancreas 2008;36:255-60. [DOI: 10.1097/mpa.0b013e31815b6b10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
32 Ino Y, Arita Y, Akashi T, Kimura T, Igarashi H, Oono T, Furukawa M, Kawabe K, Ogoshi K, Ouchi J, Miyahara T, Takayanagi R, Ito T. Continuous regional arterial infusion therapy with gabexate mesilate for severe acute pancreatitis. World J Gastroenterol 2008; 14(41): 6382-6387 [PMID: 19009656 DOI: 10.3748/wjg.14.6382] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
33 Caronna R, Diana L, Nofroni I, Sibio S, Catinelli S, Sammartino P, Chirletti P. Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice. Dig Dis Sci. 2005;50:868-873. [PMID: 15906759 DOI: 10.1007/s10620-005-2655-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
34 Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001;164:162-70. [PMID: 11435255 DOI: 10.1164/ajrccm.164.1.2008026] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 3.4] [Reference Citation Analysis]
35 Taoka Y, Okajima K. Spinal cord injury in the rat. Progress in Neurobiology 1998;56:341-58. [DOI: 10.1016/s0301-0082(98)00049-5] [Cited by in Crossref: 154] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
36 Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, Gurusamy KS. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev. 2017;4:CD011384. [PMID: 28431202 DOI: 10.1002/14651858.cd011384.pub2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
37 Pezzilli R, Miglioli M. Multicentre comparative study of two schedules of gabexate mesilate in the treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group. Dig Liver Dis. 2001;33:49-57. [PMID: 11303975 DOI: 10.1016/s1590-8658(01)80135-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
38 Takagi K, Isaji S. Therapeutic efficacy of continuous arterial infusion of an antibiotic and a protease inhibitor via the superior mesenteric artery for acute pancreatitis in an animal model. Pancreas. 2000;21:279-289. [PMID: 11039473 DOI: 10.1097/00006676-200010000-00010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
39 Hirota M, Takada T, Kitamura N, Ito T, Hirata K, Yoshida M, Mayumi T, Kataoka K, Takeda K, Sekimoto M. Fundamental and intensive care of acute pancreatitis. J Hepatobiliary Pancreat Sci. 2010;17:45-52. [PMID: 20012652 DOI: 10.1007/s00534-009-0210-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
40 Pastor CM, Matthay MA, Frossard JL. Pancreatitis-associated acute lung injury: new insights. Chest. 2003;124:2341-2351. [PMID: 14665518 DOI: 10.1378/chest.124.6.2341] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 6.2] [Reference Citation Analysis]
41 Deng ZG, Zhou JY, Yin ZY, Peng YY, Wang FQ, Wang XM. Continuous regional arterial infusion and laparotomic decompression for severe acute pancreatitis with abdominal compartment syndrome. World J Gastroenterol 2011; 17(44): 4911-4916 [PMID: 22171133 DOI: 10.3748/wjg.v17.i44.4911] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
42 Fernández-del Castillo C, Rattner D, Warshaw A. Acute pancreatitis. The Lancet 1993;342:475-9. [DOI: 10.1016/0140-6736(93)91598-g] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
43 Forsmark CE, Toskes PP. Acute Pancreatitis: Medical Management. Critical Care Clinics 1995;11:295-309. [DOI: 10.1016/s0749-0704(18)30068-x] [Cited by in Crossref: 23] [Article Influence: 0.9] [Reference Citation Analysis]
44 Bang UC, Semb S, Nøjgaard C, Bendtsen F. Pharmacological approach to acute pancreatitis. World J Gastroenterol 2008; 14(19): 2968-2976 [PMID: 18494044 DOI: 10.3748/wjg.14.2968] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
45 Navarro S. Historical review of our knowledge of acute pancreatitis. Gastroenterol Hepatol 2018;41:143.e1-143.e10. [PMID: 29249269 DOI: 10.1016/j.gastrohep.2017.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Gao HJ, Song Q, Lv FQ, Wang S, Wang YR, Luo YK, Mei XG, Tang J. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study. J Huazhong Univ Sci Technolog Med Sci 2015;35:707-11. [PMID: 26489626 DOI: 10.1007/s11596-015-1494-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Enns, Baillie. Review article: the treatment of acute biliary pancreatitis: REVIEW: THE TREATMENT OF ACUTE BILIARY PANCREATITIS. Alimentary Pharmacology & Therapeutics 1999;13:1379-89. [DOI: 10.1046/j.1365-2036.1999.00637.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
48 Büchler M, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F, Adler G, Gaus W, Rolle K, Beger HG. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology 1993;104:1165-70. [PMID: 8462805 DOI: 10.1016/0016-5085(93)90288-n] [Cited by in Crossref: 150] [Cited by in F6Publishing: 39] [Article Influence: 5.2] [Reference Citation Analysis]
49 Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, Naruo M, Okabe H, Takatsuki K. Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats: . Critical Care Medicine 1997;25:874-9. [DOI: 10.1097/00003246-199705000-00026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
50 Hasanadka R, Johnson CP, Edmiston CE. Pancreatic Infection. In: Rello J, Kollef M, Díaz E, Rodríguez A, editors. Infectious Diseases in Critical Care. Berlin: Springer Berlin Heidelberg; 2007. pp. 555-66. [DOI: 10.1007/978-3-540-34406-3_52] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
51 Rabenstein T, Roggenbuck S, Framke B, Martus P, Fischer B, Nusko G, Muehldorfer S, Hochberger J, Ell C, Hahn EG. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc. 2002;55:476-483. [PMID: 11923757 DOI: 10.1067/mge.2002.122616] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]